UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045841
Receipt number R000052333
Scientific Title Modified super-supraglottic swallow to strengthen laryngeal closure
Date of disclosure of the study information 2021/10/22
Last modified on 2021/10/22 22:39:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Modified swallowing to strengthen laryngeal closure

Acronym

Modified swallowing to strengthen laryngeal closure

Scientific Title

Modified super-supraglottic swallow to strengthen laryngeal closure

Scientific Title:Acronym

mSSGS

Region

Japan


Condition

Condition

healthy subjects

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluate the effect of modified super-supraglottic swallow

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Distance between epiglottis and arytenoid

Key secondary outcomes

position and movement in the pharynx and larynx;
rate of complete laryngeal closure;
presence or absence of penetration and aspiration;
seven grade Likert scale about ease of the procedure


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

super-supraglottic swallow with or without head flexion

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

healthy subjects who gave written informed consent

Key exclusion criteria

Subjects who had a history of stroke, neuromuscular diseases, diseases in pharynx or larynx, respiratory diseases, or upper digestive tract disorders. Speech therapists.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Yohei
Middle name
Last name Otaka

Organization

Fujita Health University

Division name

Dept. of Rehabilitation Medicine I, School of Medicine

Zip code

470-1192

Address

1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi

TEL

0562-93-2167

Email

fhur_2019@yahoo.co.jp


Public contact

Name of contact person

1st name Hitoshi
Middle name
Last name Kagaya

Organization

Fujita Health University

Division name

Dept. of Rehabilitation Medicine I, School of Medicine

Zip code

470-1192

Address

1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi

TEL

0562-93-2167

Homepage URL


Email

hkagaya2@fujita-hu.ac.jp


Sponsor or person

Institute

Fujita Health University

Institute

Department

Personal name



Funding Source

Organization

Fujita Health University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Fujita Health University

Address

1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi

Tel

0562-93-2865

Email

f-irb@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 10 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 08 Month 08 Day

Date of IRB

2020 Year 08 Month 08 Day

Anticipated trial start date

2021 Year 10 Month 22 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 10 Month 22 Day

Last modified on

2021 Year 10 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052333